YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression.
about
T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.Examination of survivin expression in 50 chordoma specimens--A histological and in vitro study.YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells.Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian CancerAssociation of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation.YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in miceDual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinomaRecent Advances on Small-Molecule Survivin Inhibitors.Rapamycin enhances the anti-angiogenesis and anti-proliferation ability of YM155 in oral squamous cell carcinoma.YM155 enhances ABT-737-mediated apoptosis through Mcl-1 downregulation in Mcl-1-overexpressed cancer cells.Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance.YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy.Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS/NO/STAT3/survivin signalling.Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells.Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines.YM155 enhances docetaxel efficacy in ovarian cancer.
P2860
Q30277635-3A09C764-E0FE-493A-A2F5-6555B1BFC4F9Q33275528-FDE39A4D-3FDE-408F-89D7-13971843AFCFQ33626354-7B87DBDB-CC55-4BFD-902C-551AA869C663Q35374920-34B43155-20AB-4A4D-837B-FF8DF865BB98Q36119145-1A57BB2A-FA87-4D09-9E35-966840F31828Q36210899-6671CF8C-44B2-4D3C-B43B-D1677CD7AB43Q36346978-BBF29AB9-BCCC-4716-BDFA-EF29FA8FDE30Q37689286-5F561F3B-B996-458A-9F26-D9D7865A8F42Q38700218-DF943B22-BF0D-498F-8FA5-CD986E9EC326Q38719564-2D142976-FB60-4F11-BCAB-0A8D7DD43237Q38741378-67FBBE5B-4539-4378-8864-435392878236Q38767465-97C2905D-F316-4682-ACBD-D5FF4C3B53D1Q38993553-5426117C-E4CB-4415-90E2-6ECC7DE80631Q47115139-B5ACD7DC-E8E8-4EF3-AA6E-449FABF78291Q49805034-32794428-4194-4D3C-AFF5-90BD0648FE9DQ52595117-DD63F63B-FAC1-4678-A8D8-F449823CCD19
P2860
YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
YM155 sensitizes ovarian cance ...... poptosis and tumor regression.
@en
YM155 sensitizes ovarian cance ...... poptosis and tumor regression.
@nl
type
label
YM155 sensitizes ovarian cance ...... poptosis and tumor regression.
@en
YM155 sensitizes ovarian cance ...... poptosis and tumor regression.
@nl
prefLabel
YM155 sensitizes ovarian cance ...... poptosis and tumor regression.
@en
YM155 sensitizes ovarian cance ...... poptosis and tumor regression.
@nl
P2093
P50
P1433
P1476
YM155 sensitizes ovarian cance ...... apoptosis and tumor regression
@en
P2093
Alberto Villanueva
Enric Condom
Fina Martinez-Soler
Jordi Ponce
P304
P356
10.1016/J.YGYNO.2013.11.013
P407
P577
2013-11-19T00:00:00Z